Skip to main content
. 2022 Jul 14;77(2):558–572. doi: 10.1002/hep.32620

FIGURE 1.

FIGURE 1

Consort diagram. Study 1, patients with severe obesity and matched controls; Study 2, patients with type 2 diabetes; and Study 3, patients screened for liver disease. LSM, liver stiffness measurement; SAF, steatosis, activity, and fibrosis; TE, transient elastography. *Reasons for not undergoing liver biopsy: TE scan on biopsy day <8 kPa (50%), patient did not consent to liver biopsy (29.5%), other reasons (20.5%).